Figure 3 from p97 Inhibition Synergistically Enhances Hypomethylating Therapy through Targeting of PLK1 in Acute Myeloid Leukemia
Year: 2026
Type: other
Abstract: Effects of the CB-5339/DAC combination on the transcriptomic landscape. A, MOLM-13 and MV-4-11 cells were treated with 500 or 1,000 nmol/L CB-5339 for 6 or 12 hours. RNA sequencing was performed, and the numbers of upregulated and downregulated genes were quantified for each experimental condition. B–E, Ingenuity Pathway Analysis of RNA sequencing results for (B and C) MOLM-13 and (D and E) MV4-11. Cell processes and disease-related and functional pathways are sorted by absolute Z-score.
Authors: Steffan T. Nawrocki, Ning Wang, Claudia M. Espitia, Harley Wu, Claudia Villa Celi, Julian Olea, Paniz Zarand, Homa Dadrastoussi, Hittu Matta, Sruthi Sureshkumar, Madison E. Gamble, Natalie L. Hakim, David Drum, Jack Angeles, Kaijin Wu, Jiang F. Zhong, Xuelian Chen, Alex Duong, Jennifer S. Carew, Kevin R. Kelly
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7166045236
Cites:
Cited by:
Related to:
